Related Experiment Video
Updated: May 31, 2026

Pediatric Animal Model of Extracorporeal Cardiopulmonary Resuscitation After Prolonged Circulatory Arrest
Published on: May 26, 2023
Extracorporeal Cardiopulmonary Resuscitation in Cardiac Arrest
Merna Abdou1, Adam A Behroozian2, Shawn Evans3
1Division of Cardiovascular Medicine, Scripps Clinic, Prebys Cardiovascular Institute, La Jolla, CA, USA.
Extracorporeal cardiopulmonary resuscitation (ECPR) offers a life-saving bridge for cardiac arrest patients. Optimal outcomes for this advanced therapy depend on careful patient selection and rapid, coordinated team response.
Area of Science:
- Cardiology
- Critical Care Medicine
- Emergency Medicine
Background:
- Refractory cardiac arrest presents significant treatment challenges.
- Extracorporeal membrane oxygenation (ECMO) has emerged as a potential salvage therapy.
Purpose of the Study:
- To review the application and outcomes of extracorporeal cardiopulmonary resuscitation (ECPR).
- To highlight the critical factors influencing ECPR success.
Main Methods:
- This review synthesizes current literature on ECPR.
- Focuses on patient selection criteria and logistical requirements for rapid deployment.
Main Results:
- ECPR is effective as salvage therapy for refractory cardiac arrest.
- Patient selection (witnessed arrest, shockable rhythm, younger age, fewer comorbidities) is crucial.
- Minimizing "low flow" time significantly impacts survival.
Conclusions:
- ECPR is a viable option across various settings, including intraprocedural, critical care, and out-of-hospital.
- Successful ECPR initiation requires precise coordination and experienced teams.
- Tailored, rapid responses are essential for optimizing patient survival in ECPR contexts.
Related Concept Videos
Cardiopulmonary Resuscitation I: Adult
Cardiopulmonary Resuscitation III: AED Use
Cardiopulmonary Resuscitation IV: Pharmacological Management
Cardiopulmonary Resuscitation II: ACLS Airway Management
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
